Anne Cambon-Thomsen is a French medical doctor specialised in human immunogenetics and health ethics, now Emeritus Research Director at CNRS, in an epidemiology and public health unit of Inserm and University Toulouse III. She published on human genetics, transplantation immunogenetics, biobanks, societal and policy aspects of genomics and biotechnologies. She is presently member of the European Group on Ethics of Science and New Technologies and a co-leader of the “Ethics, regulatory and societal implications” working group of the French plan for genomic medicine 2025.
She is also member of the international data policy committee of CODATA – the Committee on Data of the International Science Council (ISC) -, the governing board of EuroScience, the Directoire of MURS (Universal Movement for Scientific Responsibility) ; she is the Editor in chief of The Open Journal of bioresources and an ambassador of the Research Data Alliance (RDA) for health sciences and research ethics, where she co-leads the interest group SHARC (Sharing Rewards and Credit) and the working group COVID-19; she has a strong record of past activities in ethics and scientific bodies and is the research integrity officer for the University Toulouse III Paul Sabatier.
She previously directed two research Units on human immunogenetics and on population genetics, a research team on genomics and public health and a societal platform and was the first co-director-coordinator of the Common Service ELSI (Ethical, legal and societal implications) of BBMRI-ERIC, the European infrastructure on biobanking and biomolecular resources.